Vaccine distribution planned on UC campus
State's expanded COVID-19 vaccine distributon to include Ohio campuses
In an afternoon press conference held Thursday, Ohio Governor Mike DeWine announced that medical providers will soon receive delivery of COVID-19 vaccine in order to administer the vaccine to university students in Ohio. Students will be eligible to receive these designated supplies on a voluntary basis.
University of Cincinnati students are encouraged to make use of this on-campus opportunity to obtain the one-dose Johnson & Johnson, starting on April 10. The one-dose provides simple, one-time administration – no follow-up second dose weeks later. This is especially convenient for those students who are planning to leave the area and/or won’t be on campus after spring term comes to a close.
Due to national supply limitations, UC's on-campus vaccination clinic will be one of the few sources of single-dose vaccine in southwest Ohio, and we anticipate ultimately having enough vaccine to vaccinate all students wishing to do so before the end of the semester.
Vaccination clinics will begin Saturday, April 10.
- Visit the vaccine page of UC's Public Health website for updated information on planning and expected timeline.
Related Stories
New drug could help in crucial time during stroke
September 11, 2024
The University of Cincinnati's Joseph Broderick was featured in an MSN article highlighting the FASTEST trial testing a drug to treat stroke due to intracerebral hemorrhage, when blood vessels in the brain rupture and cause bleeding in the brain.
Bearcat enrollment growth beats national trends
September 11, 2024
The University of Cincinnati recorded its largest enrollment ever as the official head count landed at 53,235 students for fall semester 2024. The figure represents nearly a 4.5% increase over last year’s enrollment or an additional 2,314 students.
UC study: Boosting brain protein levels may slow decline from...
September 11, 2024
A study led by University of Cincinnati researchers found that new monoclonal antibody drugs for Alzheimer’s may slow cognitive impairment through boosting levels of the protein Aβ42 in the brain.